Open access
Sep 2026
LncRNA DLGAP1-AS2 promotes ESCC progression and indicates unfavorable prognosis via the miR-101-3p/EZH2 axis
DLGAP1-AS2 acts as a potential biomarker for unfavorable prognosis in ESCC patients and promotes malignant phenotypes of ESCC cells in vitro by regulating the miR-101-3p/EZH2 axis, enhancing proliferation and EMT, while suppressing ferroptosis.
Li-Wei Tang, Yi-Chuan Zhang, Xiang-Ting Cheng
· Discover Oncology · 0 citations